In an interview with the New York Times on Sunday, Tidmarsh said he was placed on administrative leave after raising concerns about the legal basis of a new program for the rapid approval of some drugs.
USFDA drug division chief George Tidmarsh resigns
Written By : Ruchika Sharma
Published On 2025-11-04 07:33 GMT | Update On 2025-11-04 07:33 GMT
Advertisement
George Tidmarsh, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER), has resigned amid serious concerns about his personal conduct, a spokesperson for the Department of Health and Human Services said.
Tidmarsh was placed on administrative leave following the Office of the General Counsel and Office of the Inspector General were alerted to the concerns, the spokesperson told Reuters.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.